UniSuper Management Pty Ltd Buys 4,927 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

UniSuper Management Pty Ltd raised its holdings in shares of Church & Dwight Co., Inc. (NYSE:CHD - Free Report) by 23.1% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 26,247 shares of the company's stock after purchasing an additional 4,927 shares during the quarter. UniSuper Management Pty Ltd's holdings in Church & Dwight were worth $2,748,000 as of its most recent SEC filing.

Several other institutional investors have also recently bought and sold shares of the business. YANKCOM Partnership purchased a new stake in shares of Church & Dwight in the fourth quarter worth approximately $25,000. Versant Capital Management Inc grew its holdings in Church & Dwight by 224.4% during the fourth quarter. Versant Capital Management Inc now owns 266 shares of the company's stock worth $28,000 after buying an additional 184 shares in the last quarter. Bank of Jackson Hole Trust purchased a new stake in Church & Dwight in the 4th quarter valued at $43,000. Golden State Wealth Management LLC bought a new position in Church & Dwight during the 4th quarter valued at $51,000. Finally, Whittier Trust Co. of Nevada Inc. boosted its holdings in Church & Dwight by 50.5% during the 4th quarter. Whittier Trust Co. of Nevada Inc. now owns 575 shares of the company's stock worth $60,000 after acquiring an additional 193 shares during the last quarter. Institutional investors and hedge funds own 86.60% of the company's stock.

Church & Dwight Price Performance

CHD stock traded up $3.34 during mid-day trading on Thursday, hitting $111.66. 1,145,565 shares of the stock were exchanged, compared to its average volume of 1,602,771. The business has a fifty day moving average price of $107.81 and a 200 day moving average price of $106.05. Church & Dwight Co., Inc. has a 12 month low of $96.35 and a 12 month high of $116.46. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.70 and a quick ratio of 1.24. The stock has a market capitalization of $27.48 billion, a price-to-earnings ratio of 47.11, a PEG ratio of 3.32 and a beta of 0.57.

Church & Dwight (NYSE:CHD - Get Free Report) last released its earnings results on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, hitting analysts' consensus estimates of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same period in the prior year, the business posted $0.65 earnings per share. On average, sell-side analysts anticipate that Church & Dwight Co., Inc. will post 3.7 EPS for the current year.

Church & Dwight Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Friday, February 14th were issued a dividend of $0.295 per share. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.18 annualized dividend and a dividend yield of 1.06%. This is a positive change from Church & Dwight's previous quarterly dividend of $0.28. Church & Dwight's dividend payout ratio (DPR) is currently 49.79%.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CHD shares. Truist Financial increased their target price on shares of Church & Dwight from $110.00 to $115.00 and gave the company a "buy" rating in a report on Monday, February 3rd. JPMorgan Chase & Co. decreased their price objective on shares of Church & Dwight from $107.00 to $106.00 and set an "underweight" rating for the company in a research note on Friday, February 21st. Piper Sandler cut their target price on Church & Dwight from $128.00 to $126.00 and set an "overweight" rating on the stock in a research note on Monday, February 3rd. Barclays increased their price target on Church & Dwight from $93.00 to $97.00 and gave the company an "underweight" rating in a research report on Thursday, March 27th. Finally, Stifel Nicolaus boosted their price objective on Church & Dwight from $103.00 to $105.00 and gave the stock a "hold" rating in a research report on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, Church & Dwight currently has a consensus rating of "Hold" and a consensus price target of $112.13.

Insider Buying and Selling

In related news, EVP Rene Hemsey sold 11,060 shares of the firm's stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $109.98, for a total transaction of $1,216,378.80. Following the transaction, the executive vice president now directly owns 6,437 shares in the company, valued at $707,941.26. This trade represents a 63.21 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Maynadier Patrick D. De sold 54,510 shares of the company's stock in a transaction on Monday, March 10th. The shares were sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the sale, the executive vice president now owns 10,497 shares of the company's stock, valued at $1,217,442.06. This represents a 83.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 65,570 shares of company stock worth $7,538,449 in the last 90 days. 2.00% of the stock is owned by company insiders.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products Division (SPD), and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.